Genome-wide unmasking of epigenetically silenced genes in lung adenocarcinoma from smokers and never smokers

Mathewos Tessema, Christin M. Yingling, Yushi Liu, Carmen S. Tellez, Leander V. Van Neste, Stephen S. Baylin, Steven A. Belinsky

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

Lung cancer in never smokers (NS) shows striking demographic, clinicopathological and molecular distinctions from the disease in smokers (S). Studies on selected genetic and epigenetic alterations in lung cancer identified that the frequency and profile of some abnormalities significantly differ by smoking status. This study compared the transcriptome of lung adenocarcinoma cell lines derived from S (n = 3) and NS (n = 3) each treated with vehicle (control), histone deacetylation inhibitor (trichostatin A) or DNA methylation inhibitor (5-aza-2'-deoxycytidine). Among 122 genes reexpressed following 5-aza-2'-deoxycytidine but not trichostatin A treatment in two or more cell lines (including 32 genes in S-only and 12 NS-only), methylation was validated for 80% (98/122 genes). After methylation analysis of 20 normal tissue samples and 14 additional non-small cell lung cancer cell lines (total 20), 39 genes frequently methylated in normal (>20%, 4/20) and 21 genes rarely methylated in non-small cell lung cancer (≤10%, 2/20) were excluded. The prevalence for methylation of the remaining 38 genes in lung adenocarcinomas from S (n = 97) and NS (n = 75) ranged from 8-89% and significantly differs between S and NS for CPEB1, CST6, EMILIN2, LAYN and MARVELD3 (P < 0.05). Furthermore, methylation of EMILIN2, ROBO3 and IGDCC4 was more prevalent in advanced (Stage II-IV, n = 61) than early (Stage I, n = 110) tumors. Knockdown of MARVELD3, one of the novel epigenetically silenced genes, by small interfering RNA significantly reduced anchorage-independent growth of lung cancer cells (P < 0.001). Collectively, this study has identified multiple, novel, epigenetically silenced genes in lung cancer and provides invaluable resources for the development of diagnostic and prognostic biomarkers.

Original languageEnglish (US)
Pages (from-to)1248-1257
Number of pages10
JournalCarcinogenesis
Volume35
Issue number6
DOIs
StatePublished - Jun 2014

ASJC Scopus subject areas

  • Cancer Research

Fingerprint

Dive into the research topics of 'Genome-wide unmasking of epigenetically silenced genes in lung adenocarcinoma from smokers and never smokers'. Together they form a unique fingerprint.

Cite this